NCT03215810 2023-07-24Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed20 enrolled 10 charts
NCT01967823 2021-03-24T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerNational Institutes of Health Clinical Center (CC)Phase 2 Completed11 enrolled 12 charts